Delivery Order SPE2DB22D1106-SPE2DB24FEVD2
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, provides for the delivery of VYVANSE 10 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The $1,814.90 firm fixed price Delivery Order does not have a set-aside designation and is scheduled for completion by September 11, 2024. Amerisourcebergen, as a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery vehicles (IDCs) to supply a wide range of essential...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,660.67 Firm Fixed Price Delivery Order contract is for the supply of 4567394215 ! VYVANSE 70 MG CAPSULE 100S. The contract has an ultimate completion date of February 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,520.95, placed under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the provision of VYVANSE 30 MG CAPSULE 100S, a prescription medication, to support the Department of Defense's medical requirements. Amerisourcebergen, a major pharmaceutical distributor, holds a single-award IDC with the DLA valued up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is a delivery order valued at $2,603.07. It was issued by the Defense Logistics Agency (DLA), a defense agency, to provide VYVANSE 10 MG CAPSULE 100S, a pharmaceutical product, with an ultimate completion date of April 1, 2024. The award is a firm fixed price contract and does not have a set-aside designation. Amerisourcebergen Drug Corp,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was made by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,898.76 Firm Fixed Price Delivery Order is for the supply of 4565392643 VYVANSE 20 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is for the delivery of VYVANSE 70 MG CAPSULE 100S, a pharmaceutical product. The contract, valued at $1,129.08, was awarded by the Defense Logistics Agency (DLA) on July 19, 2024 and has a completion date of July 22, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, provides for the delivery of 4,564,491,226 units of the pharmaceutical product VYVANSE 20MG CAPSULE 100S to the Defense Logistics Agency (DLA). The firm-fixed-price contract, valued at $4,888.61, has a period of performance through May 6, 2024 and was awarded on May 3, 2024. Amerisourcebergen, a large pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. The contract, valued at $5,556.49, was awarded by the Defense Logistics Agency (DLA), a defense agency, on June 5, 2024 and has a completion date of June 6, 2024. The contract is a delivery order with a firm fixed price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VYVANSE 50 MG CAPSULE 100S, a prescription medication, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $2,276.50, has an ultimate completion date of April 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has been awarded this contract without any set-aside designation, indicating it was a full and open competition. The...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product. The $2,003.28 firm fixed-price delivery order was awarded on May 21, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 22, 2024. The contract is not set aside for any specific business type. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEVD2Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564804602 VYVANSE 10 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The $1,724.00 firm fixed price contract has a completion date of June 5, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense globally. This specific delivery order is not designated as a set-aside. Amerisourcebergen's extensive federal contracting experience and logistics capabilities enable it to efficiently fulfill critical medical product requirements for various government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 6/4/24 |